Global Diabetic Retinopathy Market research report makes use of SWOT analysis and Porter’s Five Forces analysis to disclose the strengths, weaknesses, opportunities, and threats in the HELATH industry. This report is an important source of guidance for companies and individuals offering industry chain structure, business strategies and proposals for new project investments.
In recent years, the diabetic retinopathy market is anticipated to grow rapidly during the forecast period. Diabetic retinopathy (DR) is the most common cause of visual loss worldwide. The duration of hyperglycemia, diabetes and hypertension are the most clinically important risk factors for vision loss progression. Controlling blood sugar and blood pressure has been demonstrated to help prevent vision loss due to diabetic retinopathy. According to the International Diabetes Federation (IDF), the global prevalence of diabetes mellitus (DM) was around 27% from 2015 to 2019. The lowest rates were found in Europe (20.6%) and Southeast Asia (12.5%), while the most significant rates were found in Africa (33.8%), the Middle East and North Africa (33.8%), and the Western Pacific region (36.2%).
Data Bridge Market Research analyses that the diabetic retinopathy market was valued at USD 6.60 billion in 2021 and is expected to reach USD 12.68 billion by 2029, registering a CAGR of 8.50% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
View Detailed Report@ https://www.databridgemarketresearch.com/reports/global-diabetic-retinopathy-market
Diabetes mellitus damages the blood vessels in the retina, resulting in diabetic retinopathy (DR). There are two types of diabetic retinopathy: non-proliferative and proliferative or progressed diabetic retinopathy. It is caused by changes in blood glucose levels, which cause abnormal growth of the light-sensitive structures in the eye. Dark patches or floating strings in the vision field, hazy or fluctuating vision, decreased colour vision, or vision loss are all symptoms of diabetic retinopathy.
Recent Development
In August 2020, Eyenuk had announced the U.S. Food and Drug Administration (FDA) approval for EyeArt Autonomous AI System for diabetic retinopathy screening. EyeArt is designed to help healthcare providers detect more than moderate diabetic retinopathy (mtmDR) and vision-threatening diabetic retinopathy (vtDR) in the eyes of adults with diabetes who have never been diagnosed with more than mild diabetic retinopathy.
this business report introduces the basics of industry such as market definitions, classifications, applications and industry chain overview, after which it covers industry policies and plans, product specifications, manufacturing processes, cost structures and so on.
This Market Intelligence Report Analyses Some of the Most Crucial Concerns:
- How will the major segments of this international market develop over the next few years?
- Who are the major players that will dominate the market in the future?
- When it comes to this industry, who are the top suppliers and producers?
- How have the most successful companies in the industry planned for future growth and expansion?
- In what sectors might we expect to see the greatest increase in demand over the coming years?
- How many distinct subsets of buyers make up this market?
- Which regional powerhouse do you foresee as becoming the largest player in the international market?
- Does a new coronavirus pandemic have any consequences?
- In what ways are established actors stymied by the entry of newcomers, and how may they be overcome?
Diabetic Retinopathy Market Scope
Type
- Non-Proliferative Diabetic Retinopathy
- Proliferative Diabetic Retinopathy
Type segment for the diabetic retinopathy market is categorized into non-proliferative diabetic retinopathy and proliferative diabetic retinopathy.
Treatment
- Medication
- Device
- Surgery
- Others
Based on treatment, the diabetic retinopathy market is segmented into medication, device, surgery and others. The medication section is further categorized into anti-vascular endothelial growth factor drug, intravitreal steroid, lipid lowering drugs and others. The device section has been sub-segmented into focal laser, vitrectomy devices, scatter laser and others.
Diagnosis
- Fluorescein Angiography
- Optical Coherence Tomography
- Others
Based on diagnosis, the diabetic retinopathy market is segmented into fluorescein angiography, optical coheence tomography and others.
Route of Administration
- Oral
- Intravitreal Injections
- Intravitreal Implants
- Others
The route of administration segment for global diabetic retinopathy market is segmented into oral, intravitreal injections, intravitreal implants and others.
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
On the basis of end-users, the diabetic retinopathy market is segmented into hospitals, specialty clinics, homecare and others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Investing in this study would grant you access to valuable information, including:
- Regional-level breakdowns of the market, including North America, Europe, Asia Pacific, South America, and the Middle East & Africa.
- Country-specific market size splits for the most important countries with major market shares.
- Market share and revenue/sales data for the industry's leading players.
- Analysis of market trends such as emerging technologies, products, and start-ups, as well as PESTEL Analysis, SWOT Analysis, Porter's Five Forces, and more.
- Detailed market size data, including breakdowns by application/industry verticals.
- Projections and forecasts for the market's future growth and development.
More Links:
https://www.databridgemarketresearch.com/reports/global-uterotonic-agent-market
https://www.databridgemarketresearch.com/reports/global-hematuria-treatment-market
https://www.databridgemarketresearch.com/reports/global-antidotes-market
https://www.databridgemarketresearch.com/reports/global-cephalosporins-market
https://www.databridgemarketresearch.com/reports/global-sicca-syndrome-sjogren-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decisionmaking process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: corporatesales@databridgemarketresearch.com
